Pseudomyxoma peritonei as an intractable disease and its preoperative assessment to help improve prognosis after surgery: A review of the literature

10Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Pseudomyxoma peritonei (PMP) is a rare and intractable disease with an estimated incidence of one per million population per year. Many aspects of PMP need to be fully and precisely understood; these include its preoperative assessment, i.e. diagnosis, early diagnosis, pathologic classification, and staging according to the peritoneal cancer index, and its surgical treatment. This review focuses on elements of preoperative assessment and surgery using the Sugarbaker procedure to help improve the prognosis for patients with PMP. Accurate data on the incidence of PMP must be based on large populations rather than estimates, and much work needs to be done especially in China. Special attention should be paid to its preoperative assessment. Also proposed here are steps to manage PMP with an emphasis on preoperative assessment. © 2012, International Research and Cooperation Association for Bio & Socio-Sciences Advancement. All rights reserved.

Cite

CITATION STYLE

APA

Zhong, Y., Deng, M., Xu, R., Zhong, Y., Kokudo, N., & Tang, W. (2012). Pseudomyxoma peritonei as an intractable disease and its preoperative assessment to help improve prognosis after surgery: A review of the literature. Intractable and Rare Diseases Research, 1(3), 115–121. https://doi.org/10.5582/irdr.2012.v1.3.115

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free